Good Samaritan Medical Center Opens the Bariatric & Metabolic Institute for Surgical Weight Loss

Good Samaritan Medical Center, part of the Palm Beach Health Network, is now offering patients another option to lose weight with the opening of the Bariatric & Metabolic Institute for Surgical Weight Loss.  Colorectal, general, robotic, and bariatric surgeon, Dr. Eduardo Parra-Davila, and general and robotic surgeon, Dr. Abraham Betancourt lead the program.  

“Bariatric surgery is an extremely safe and effective way forpeople looking to lose weight, and get back to leading a healthier, more active lifestyle,” said Dr. Parra-Davila.  “The benefits of these procedures are life changing for our patients, and can even lower someone’s chances of heart disease, diabetes, and cancer.  We are proud to be able to offer this new service to our community

Some of the procedures and services offered at the institute include:

Gastric Sleeve Surgery
Adjustable Gastric Band
Revision Bariatric Surgery
Ingastric Balloon Surgery
Bariatric Classes and Events
Bariatric Nurse Navigator

“We are committed to providing and adding new services for our community to get some of the best care right here in Palm Beach County,” said Sheri Montgomery, chief executive officer of Good Samaritan Medical Center. “Our bariatric institute has several surgical options designed to fit what works best for a patient’s ultimate weight loss goals.”

More

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version